aser therapy in Patients with Rapids Maxillary Expansion needs

Not Applicable

• Conditions: M01.060.406; Mouth Abnormalities; Maxilla; Child; C07.465.525; A02.835.232.781.324.502.645

• Registration Number: RBR-6y979g
• Lead Sponsor: niversidade Federal de Santa Maria

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-12-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients in the mixed dentition phase; maxillary atresia

Exclusion Criteria

Patients with previous orthodontic treatment history; that require other modalities of interceptive orthodontic treatment within the experimental period (10 months); systemic diseases that interfere with bone metabolism, or use medications that alter bone metabolism; craniofacial malformations; suspected or diagnosed oral cancer

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expected outcome 1: Stability of maxillary expansion on the day of stabilization of the expander screw, 3 months after screw stabilization, immediately after removal of the expander (after 6 months of containment) and 3 months after removal of the expander; verified through intercanine and intermolar distances in gypsum models in each phase through digital caliper; from the observation of a variation at least 5% in the pre and post intervention values.;Expected outcome 2: Mineral density of the palatine suture on the day of stabilization of the expander screw, 3 months after screw stabilization, immediately after removal of the expander (after 6 months of containment) and 3 months after removal of the expander; verified by measuring the optical density in the anterior region of the medial palatine suture in periapical radiographs, obtained by the parallelism technique with positioning; from the observation of a variation at least 5% in the pre and post intervention values.

Secondary Outcome Measures

Name	Time	Method
Expected outcome 3: Dimension of the airway after 3 months of removal of the maxillary expander; verified by measuring the volume of the airways by tomography; from the observation of a variation at least 5% in the pre and post intervention values.;Expected outcome 4: Improvement in quality of life after 3 months of removal of the maxillary expander; verified by the Child Perceptions Questionnaire (B-CPQ) for children 8 to 10 years and 11 to 14 years; from the observation of at least 5% in the pre and post intervention values.;Expected outcome 5: Pain sensitivity variation on the day of stabilization of the expander screw, 3 months after screw stabilization, immediately after removal of the expander (after 6 months of containment) and 3 months after removal of the expander; verified through the visual analogue scale (VAS); from the observation of at least 5% in the pre and post intervention values.